Rosiglitazone and pioglitazone: Beware fractures

BMJ (Online)

Volumn 339, Issue 7724, 2009, Pages 766-

  Dixit, Alok ^a   Pandey, Pinki ^a  

^a MAHARISHI MARKANDESHWAR INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE; ANTIDIABETIC AGENT;

CLINICAL STUDY; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; FRACTURE; HEALTH PRACTITIONER; HUMAN; LETTER; LIVER TOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; CHEMICALLY INDUCED DISORDER; FEMALE; MALE; NOTE;

DIABETES MELLITUS, TYPE 2; FEMALE; FRACTURES, BONE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; THIAZOLIDINEDIONES;

EID: 70349644691     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3957     Document Type: Letter

References (5)

1. Juurlink DN, Gomes T, Lipscombe LL, Austin PC, Hux JE, Mamdani MM. Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ 2009;339:b2942. (18 August.)[Abstract/Free Full Text]
2. Pioglitazone. WHO Pharmaceuticals Newsletter 2007;3:5.
3. Dormuth CR, Carney G, Carleton B, Bassett K, Wright JM. Thiazolidinediones and fractures in men and women. Arch Intern Med 2009;169:1395-1402[Abstract/Free Full Text]
4. Jones SG, Momin SR, Good MW, Shea TK, Patric K. Distal upper and lower limb fractures associated with thiazolidinedione use. Am J Manag Care 2009;15:491-496[Web of Science][Medline]
5. Loke YK, Sinkh S, Furberg CD. Long term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 2009;180:32-39[Abstract/Free Full Text]